Vivet opens enrollment in phase I/II study of VTX-801 gene therapy for Wilson's disease April 26, 2021
Neurodevelopmental and biomarker data for RGX-121 in a phase I/II study for severe MPS II April 26, 2021
ProtoKinetix resumes phase I trials of PKX-001-treated islet cells in patients with type 1 diabetes April 23, 2021
Optimization of indolinylpyrimidine derivatives to obtain potent orally bioavailable GPR119 agonists April 19, 2021
A new benzimidazole series of selective and potent inhibitors of long-chain acyl-CoA synthetase April 15, 2021
RSS